| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Milk, Human | 57 | 2023 | 156 | 15.070 |
Why?
|
| Breast Feeding | 55 | 2023 | 155 | 12.520 |
Why?
|
| Infant, Very Low Birth Weight | 50 | 2022 | 162 | 11.410 |
Why?
|
| Intensive Care Units, Neonatal | 58 | 2022 | 182 | 9.970 |
Why?
|
| Infant, Premature | 58 | 2022 | 178 | 9.220 |
Why?
|
| Mothers | 39 | 2022 | 178 | 8.620 |
Why?
|
| Infant, Newborn | 106 | 2023 | 604 | 6.650 |
Why?
|
| Lactation | 23 | 2023 | 62 | 5.530 |
Why?
|
| Breast Milk Expression | 13 | 2020 | 40 | 5.260 |
Why?
|
| Intensive Care, Neonatal | 11 | 2020 | 34 | 3.420 |
Why?
|
| Infant Nutritional Physiological Phenomena | 26 | 2023 | 61 | 3.360 |
Why?
|
| Infant | 28 | 2023 | 531 | 2.330 |
Why?
|
| Enterocolitis, Necrotizing | 11 | 2020 | 33 | 2.310 |
Why?
|
| Female | 78 | 2023 | 16197 | 1.920 |
Why?
|
| Mother-Child Relations | 7 | 2017 | 40 | 1.910 |
Why?
|
| Humans | 109 | 2023 | 29337 | 1.760 |
Why?
|
| Child Development | 10 | 2020 | 71 | 1.710 |
Why?
|
| Infant, Premature, Diseases | 7 | 2020 | 26 | 1.650 |
Why?
|
| Neonatal Nursing | 12 | 2018 | 20 | 1.600 |
Why?
|
| Gestational Age | 16 | 2020 | 73 | 1.500 |
Why?
|
| Peer Group | 6 | 2017 | 40 | 1.450 |
Why?
|
| Social Support | 6 | 2019 | 185 | 1.330 |
Why?
|
| Maternal Behavior | 4 | 2017 | 14 | 1.320 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2019 | 13 | 1.240 |
Why?
|
| Milk Banks | 6 | 2020 | 22 | 1.110 |
Why?
|
| Adult | 37 | 2020 | 8601 | 1.090 |
Why?
|
| Health Care Costs | 5 | 2020 | 70 | 1.090 |
Why?
|
| Bottle Feeding | 8 | 2016 | 14 | 1.090 |
Why?
|
| Prospective Studies | 18 | 2019 | 1811 | 1.040 |
Why?
|
| Counseling | 5 | 2013 | 48 | 0.970 |
Why?
|
| Postpartum Period | 3 | 2021 | 24 | 0.960 |
Why?
|
| Goals | 4 | 2017 | 43 | 0.930 |
Why?
|
| Infant, Low Birth Weight | 7 | 2019 | 16 | 0.910 |
Why?
|
| Precision Medicine | 1 | 2022 | 24 | 0.880 |
Why?
|
| Infant, Newborn, Diseases | 4 | 2020 | 17 | 0.880 |
Why?
|
| Patient Discharge | 8 | 2019 | 149 | 0.860 |
Why?
|
| Male | 36 | 2020 | 15621 | 0.830 |
Why?
|
| Socioeconomic Factors | 4 | 2020 | 328 | 0.810 |
Why?
|
| Postnatal Care | 2 | 2013 | 7 | 0.800 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 75 | 0.770 |
Why?
|
| Social Determinants of Health | 1 | 2020 | 27 | 0.760 |
Why?
|
| Educational Status | 5 | 2019 | 295 | 0.760 |
Why?
|
| Nutritive Value | 5 | 2020 | 20 | 0.740 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 22 | 0.730 |
Why?
|
| Enteral Nutrition | 4 | 2018 | 49 | 0.730 |
Why?
|
| Contraception Behavior | 1 | 2019 | 6 | 0.710 |
Why?
|
| Health Promotion | 4 | 2013 | 161 | 0.700 |
Why?
|
| Anthropometry | 6 | 2007 | 37 | 0.660 |
Why?
|
| Sepsis | 3 | 2019 | 144 | 0.660 |
Why?
|
| Birth Weight | 7 | 2020 | 34 | 0.630 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2019 | 189 | 0.620 |
Why?
|
| Hospitalization | 6 | 2019 | 317 | 0.610 |
Why?
|
| Child Language | 2 | 2017 | 11 | 0.600 |
Why?
|
| Chicago | 7 | 2017 | 865 | 0.600 |
Why?
|
| Stress, Psychological | 2 | 2019 | 246 | 0.590 |
Why?
|
| Resilience, Psychological | 1 | 2017 | 24 | 0.580 |
Why?
|
| Depression, Postpartum | 2 | 2017 | 16 | 0.570 |
Why?
|
| Puerperal Disorders | 1 | 2015 | 8 | 0.540 |
Why?
|
| Infant Formula | 6 | 2020 | 22 | 0.530 |
Why?
|
| Cost Savings | 1 | 2015 | 36 | 0.520 |
Why?
|
| Infant Care | 5 | 2016 | 15 | 0.520 |
Why?
|
| Young Adult | 7 | 2019 | 1932 | 0.520 |
Why?
|
| Longitudinal Studies | 8 | 2019 | 1442 | 0.510 |
Why?
|
| Energy Intake | 4 | 2018 | 66 | 0.500 |
Why?
|
| Suction | 3 | 2010 | 41 | 0.500 |
Why?
|
| Weight Gain | 5 | 2018 | 66 | 0.500 |
Why?
|
| Infant, Extremely Low Birth Weight | 3 | 2012 | 20 | 0.490 |
Why?
|
| Research Support as Topic | 2 | 2005 | 17 | 0.490 |
Why?
|
| Retinopathy of Prematurity | 1 | 2014 | 5 | 0.490 |
Why?
|
| Retrospective Studies | 11 | 2020 | 3273 | 0.480 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 168 | 0.480 |
Why?
|
| Intestines | 2 | 2013 | 107 | 0.480 |
Why?
|
| Patient Education as Topic | 5 | 2013 | 162 | 0.470 |
Why?
|
| Motor Activity | 2 | 2017 | 369 | 0.470 |
Why?
|
| Direct Service Costs | 1 | 2012 | 4 | 0.440 |
Why?
|
| Hospital Costs | 1 | 2013 | 68 | 0.440 |
Why?
|
| Attitude to Health | 1 | 2013 | 97 | 0.430 |
Why?
|
| Premature Birth | 2 | 2023 | 6 | 0.430 |
Why?
|
| Perception | 2 | 2020 | 83 | 0.420 |
Why?
|
| Breast | 2 | 2008 | 16 | 0.410 |
Why?
|
| Risk Factors | 7 | 2016 | 2443 | 0.390 |
Why?
|
| Nurse's Role | 5 | 2007 | 118 | 0.380 |
Why?
|
| Reproducibility of Results | 10 | 2006 | 788 | 0.380 |
Why?
|
| Incidence | 6 | 2020 | 756 | 0.370 |
Why?
|
| Nurseries, Hospital | 2 | 2007 | 4 | 0.360 |
Why?
|
| United States | 10 | 2020 | 2333 | 0.360 |
Why?
|
| Clinical Nursing Research | 2 | 2002 | 11 | 0.340 |
Why?
|
| Diet | 3 | 2018 | 174 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 333 | 0.340 |
Why?
|
| Lipids | 2 | 2006 | 36 | 0.330 |
Why?
|
| Cognition | 2 | 2017 | 1277 | 0.330 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2017 | 194 | 0.330 |
Why?
|
| Qualitative Research | 4 | 2017 | 112 | 0.330 |
Why?
|
| Child, Preschool | 2 | 2020 | 642 | 0.320 |
Why?
|
| Body Weight | 6 | 1996 | 133 | 0.320 |
Why?
|
| Child | 4 | 2021 | 1346 | 0.320 |
Why?
|
| Biomarkers | 3 | 2020 | 689 | 0.310 |
Why?
|
| Anxiety | 2 | 2019 | 152 | 0.310 |
Why?
|
| Animals | 7 | 2020 | 4552 | 0.300 |
Why?
|
| Maternal Age | 3 | 2019 | 15 | 0.290 |
Why?
|
| Interviews as Topic | 3 | 2017 | 130 | 0.290 |
Why?
|
| Residence Characteristics | 2 | 2019 | 216 | 0.290 |
Why?
|
| Costs and Cost Analysis | 2 | 2019 | 36 | 0.290 |
Why?
|
| Maternal-Child Nursing | 2 | 2004 | 5 | 0.290 |
Why?
|
| Centrifugation | 1 | 2006 | 4 | 0.280 |
Why?
|
| Colostrum | 3 | 2010 | 5 | 0.280 |
Why?
|
| Milk Ejection | 3 | 2011 | 5 | 0.270 |
Why?
|
| Decision Making | 4 | 2015 | 220 | 0.270 |
Why?
|
| Child Nutrition Sciences | 1 | 2005 | 3 | 0.260 |
Why?
|
| Research | 1 | 2005 | 54 | 0.260 |
Why?
|
| Parent-Child Relations | 1 | 2004 | 33 | 0.250 |
Why?
|
| Evidence-Based Practice | 2 | 2016 | 77 | 0.250 |
Why?
|
| Adolescent | 7 | 2017 | 2279 | 0.250 |
Why?
|
| Mass Media | 1 | 2004 | 6 | 0.250 |
Why?
|
| Cohort Studies | 6 | 2020 | 1939 | 0.240 |
Why?
|
| Parents | 1 | 2004 | 105 | 0.230 |
Why?
|
| Nursing Evaluation Research | 4 | 2015 | 54 | 0.230 |
Why?
|
| Financing, Government | 1 | 2003 | 14 | 0.230 |
Why?
|
| Nutritional Status | 2 | 2020 | 39 | 0.230 |
Why?
|
| Pregnancy | 7 | 2019 | 403 | 0.230 |
Why?
|
| Aftercare | 3 | 2018 | 22 | 0.220 |
Why?
|
| Health Policy | 1 | 2003 | 50 | 0.220 |
Why?
|
| Cost of Illness | 2 | 2013 | 54 | 0.220 |
Why?
|
| Nutritional Support | 3 | 2018 | 18 | 0.210 |
Why?
|
| Attitude of Health Personnel | 2 | 2013 | 148 | 0.200 |
Why?
|
| Oxidative Stress | 2 | 2018 | 124 | 0.200 |
Why?
|
| Health Expenditures | 1 | 2020 | 19 | 0.190 |
Why?
|
| Neonatology | 1 | 2020 | 3 | 0.190 |
Why?
|
| Age Factors | 2 | 2020 | 843 | 0.190 |
Why?
|
| Nipples | 1 | 2000 | 1 | 0.190 |
Why?
|
| Protective Devices | 1 | 2000 | 2 | 0.190 |
Why?
|
| Tissue Donors | 2 | 2021 | 74 | 0.190 |
Why?
|
| Cost-Benefit Analysis | 3 | 2020 | 144 | 0.180 |
Why?
|
| Child of Impaired Parents | 1 | 2019 | 11 | 0.180 |
Why?
|
| Linear Models | 3 | 2017 | 254 | 0.180 |
Why?
|
| Directive Counseling | 1 | 2019 | 12 | 0.180 |
Why?
|
| Intention | 1 | 2019 | 26 | 0.170 |
Why?
|
| Body Mass Index | 1 | 2021 | 428 | 0.170 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 52 | 0.170 |
Why?
|
| Intestinal Mucosa | 2 | 2018 | 220 | 0.170 |
Why?
|
| Time Factors | 6 | 2018 | 1616 | 0.170 |
Why?
|
| Acute Disease | 1 | 2019 | 226 | 0.170 |
Why?
|
| Program Evaluation | 2 | 2013 | 132 | 0.170 |
Why?
|
| Return to Work | 2 | 2016 | 52 | 0.170 |
Why?
|
| Toxoplasmosis, Congenital | 2 | 2011 | 26 | 0.170 |
Why?
|
| Obesity | 1 | 2021 | 291 | 0.170 |
Why?
|
| Pilot Projects | 2 | 2018 | 394 | 0.170 |
Why?
|
| Social Class | 1 | 2019 | 64 | 0.170 |
Why?
|
| Inflammation | 2 | 2018 | 344 | 0.170 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 324 | 0.170 |
Why?
|
| Cell Death | 1 | 2018 | 61 | 0.160 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 1830 | 0.160 |
Why?
|
| Biomedical Research | 2 | 2016 | 81 | 0.160 |
Why?
|
| Depression | 2 | 2019 | 465 | 0.160 |
Why?
|
| Sucking Behavior | 2 | 1994 | 2 | 0.160 |
Why?
|
| Nervous System | 1 | 2017 | 11 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 79 | 0.160 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 20 | 0.150 |
Why?
|
| Pregnancy in Adolescence | 1 | 2017 | 12 | 0.150 |
Why?
|
| Narration | 1 | 2017 | 12 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 402 | 0.150 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 65 | 0.150 |
Why?
|
| Tissue and Organ Procurement | 1 | 2016 | 34 | 0.150 |
Why?
|
| Science | 1 | 1996 | 4 | 0.140 |
Why?
|
| Nurse-Patient Relations | 2 | 2015 | 40 | 0.140 |
Why?
|
| Program Development | 2 | 2014 | 69 | 0.140 |
Why?
|
| Weaning | 1 | 2016 | 5 | 0.140 |
Why?
|
| Nutrition Assessment | 1 | 1996 | 31 | 0.140 |
Why?
|
| Adaptation, Psychological | 1 | 2017 | 143 | 0.140 |
Why?
|
| Illinois | 1 | 2016 | 241 | 0.140 |
Why?
|
| Informed Consent | 1 | 2015 | 19 | 0.140 |
Why?
|
| Bacteria | 1 | 2016 | 77 | 0.140 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 67 | 0.140 |
Why?
|
| Nigeria | 2 | 2007 | 4 | 0.140 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 2015 | 6 | 0.140 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2015 | 14 | 0.130 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 55 | 0.130 |
Why?
|
| Incubators, Infant | 2 | 1995 | 2 | 0.130 |
Why?
|
| Life Change Events | 1 | 2015 | 36 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1113 | 0.130 |
Why?
|
| Length of Stay | 1 | 2017 | 317 | 0.130 |
Why?
|
| Home Nursing | 1 | 1994 | 18 | 0.130 |
Why?
|
| Beds | 1 | 1994 | 3 | 0.130 |
Why?
|
| Ambulatory Care | 1 | 2015 | 75 | 0.130 |
Why?
|
| Focus Groups | 1 | 1994 | 84 | 0.120 |
Why?
|
| Morbidity | 1 | 2014 | 63 | 0.120 |
Why?
|
| Milk | 2 | 2012 | 9 | 0.120 |
Why?
|
| Swine | 1 | 2013 | 80 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 553 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2015 | 123 | 0.120 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 39 | 0.120 |
Why?
|
| Clinical Chemistry Tests | 2 | 2006 | 4 | 0.120 |
Why?
|
| Nursing Staff, Hospital | 2 | 1993 | 62 | 0.120 |
Why?
|
| Guilt | 1 | 2013 | 3 | 0.120 |
Why?
|
| Models, Animal | 1 | 2013 | 126 | 0.120 |
Why?
|
| Feeding Methods | 1 | 2013 | 3 | 0.110 |
Why?
|
| Organizational Culture | 1 | 2013 | 19 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2016 | 180 | 0.110 |
Why?
|
| Propensity Score | 1 | 2013 | 34 | 0.110 |
Why?
|
| Surveys and Questionnaires | 3 | 2015 | 1184 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2014 | 158 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2012 | 6 | 0.110 |
Why?
|
| Morphogenesis | 1 | 2012 | 7 | 0.110 |
Why?
|
| Quadruplets | 1 | 1992 | 1 | 0.110 |
Why?
|
| Motivation | 1 | 2013 | 100 | 0.110 |
Why?
|
| Microbiota | 1 | 2013 | 105 | 0.110 |
Why?
|
| Body Height | 1 | 1992 | 33 | 0.110 |
Why?
|
| Food Contamination | 1 | 2011 | 4 | 0.110 |
Why?
|
| Toxoplasma | 1 | 2011 | 18 | 0.100 |
Why?
|
| Eating | 1 | 2011 | 45 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 138 | 0.100 |
Why?
|
| Reference Values | 1 | 2011 | 227 | 0.100 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2010 | 6 | 0.100 |
Why?
|
| Lactoferrin | 1 | 2010 | 12 | 0.100 |
Why?
|
| Cultured Milk Products | 1 | 2009 | 2 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3478 | 0.090 |
Why?
|
| Models, Nursing | 2 | 2004 | 32 | 0.090 |
Why?
|
| Evidence-Based Medicine | 2 | 2020 | 208 | 0.090 |
Why?
|
| Infant Food | 2 | 2004 | 2 | 0.080 |
Why?
|
| Personal Satisfaction | 1 | 2008 | 47 | 0.080 |
Why?
|
| Midwifery | 1 | 2007 | 2 | 0.080 |
Why?
|
| Observer Variation | 6 | 2000 | 118 | 0.080 |
Why?
|
| Nursing Diagnosis | 1 | 2007 | 4 | 0.080 |
Why?
|
| Equipment Design | 2 | 2007 | 185 | 0.080 |
Why?
|
| Kenya | 1 | 2007 | 7 | 0.080 |
Why?
|
| Models, Biological | 1 | 2009 | 343 | 0.080 |
Why?
|
| Data Collection | 2 | 2002 | 107 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2007 | 321 | 0.070 |
Why?
|
| North America | 2 | 2018 | 38 | 0.070 |
Why?
|
| Risk Management | 1 | 2005 | 5 | 0.070 |
Why?
|
| Ethics, Research | 1 | 2005 | 3 | 0.070 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2005 | 7 | 0.070 |
Why?
|
| Toxoplasmosis | 1 | 2005 | 10 | 0.070 |
Why?
|
| Object Attachment | 1 | 2004 | 1 | 0.070 |
Why?
|
| Prenatal Diagnosis | 1 | 2005 | 15 | 0.060 |
Why?
|
| Nursing Methodology Research | 1 | 2004 | 24 | 0.060 |
Why?
|
| Nursing Assessment | 1 | 2005 | 44 | 0.060 |
Why?
|
| Logistic Models | 2 | 2016 | 407 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2005 | 90 | 0.060 |
Why?
|
| Clinical Protocols | 2 | 2014 | 65 | 0.060 |
Why?
|
| Health Planning Support | 1 | 2003 | 1 | 0.060 |
Why?
|
| Healthy People Programs | 1 | 2003 | 2 | 0.060 |
Why?
|
| Databases, Bibliographic | 1 | 2003 | 11 | 0.060 |
Why?
|
| Policy Making | 1 | 2003 | 15 | 0.060 |
Why?
|
| Politics | 1 | 2003 | 17 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2003 | 30 | 0.060 |
Why?
|
| Conflict of Interest | 1 | 2003 | 18 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2003 | 227 | 0.050 |
Why?
|
| Holistic Nursing | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cross Infection | 1 | 2005 | 298 | 0.050 |
Why?
|
| Silicones | 1 | 2000 | 8 | 0.050 |
Why?
|
| Research Design | 1 | 2002 | 212 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 340 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2020 | 69 | 0.050 |
Why?
|
| Risk | 1 | 2020 | 217 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 3 | 1994 | 56 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 101 | 0.040 |
Why?
|
| Administration, Oral | 2 | 2010 | 140 | 0.040 |
Why?
|
| Oceania | 1 | 2018 | 2 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 9 | 0.040 |
Why?
|
| Africa | 1 | 2018 | 10 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 1996 | 118 | 0.040 |
Why?
|
| North Carolina | 1 | 2018 | 5 | 0.040 |
Why?
|
| Internationality | 1 | 2018 | 24 | 0.040 |
Why?
|
| Europe | 1 | 2018 | 81 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 330 | 0.040 |
Why?
|
| Food, Fortified | 1 | 2018 | 5 | 0.040 |
Why?
|
| F2-Isoprostanes | 1 | 2018 | 5 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 638 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 53 | 0.040 |
Why?
|
| Income | 1 | 2018 | 74 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 127 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 215 | 0.040 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 43 | 0.040 |
Why?
|
| Health | 1 | 1996 | 9 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 48 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 37 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2016 | 56 | 0.030 |
Why?
|
| Phylogeny | 1 | 2016 | 63 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 98 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2015 | 13 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 26 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 27 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2015 | 107 | 0.030 |
Why?
|
| Cell Line | 1 | 2015 | 298 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 251 | 0.030 |
Why?
|
| Transportation of Patients | 1 | 1994 | 6 | 0.030 |
Why?
|
| Group Processes | 1 | 1994 | 9 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 100 | 0.030 |
Why?
|
| Research Personnel | 1 | 1994 | 20 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 1994 | 38 | 0.030 |
Why?
|
| Nurse Clinicians | 1 | 1994 | 25 | 0.030 |
Why?
|
| Consultants | 1 | 1993 | 1 | 0.030 |
Why?
|
| Workload | 1 | 1993 | 33 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 2012 | 1 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2012 | 55 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 14 | 0.030 |
Why?
|
| Fetal Development | 1 | 2012 | 3 | 0.030 |
Why?
|
| Cesarean Section | 1 | 1992 | 30 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 80 | 0.030 |
Why?
|
| Oocysts | 1 | 2011 | 3 | 0.030 |
Why?
|
| Antibodies, Protozoan | 1 | 2011 | 12 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2012 | 33 | 0.030 |
Why?
|
| Immunoassay | 1 | 2011 | 41 | 0.030 |
Why?
|
| Patient Care Team | 1 | 1993 | 140 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2011 | 34 | 0.030 |
Why?
|
| Bodily Secretions | 1 | 2010 | 1 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 1607 | 0.020 |
Why?
|
| Methods | 1 | 1990 | 18 | 0.020 |
Why?
|
| Weights and Measures | 1 | 1990 | 8 | 0.020 |
Why?
|
| Cephalometry | 1 | 1989 | 3 | 0.020 |
Why?
|
| Trachea | 1 | 2010 | 31 | 0.020 |
Why?
|
| Equipment and Supplies | 1 | 1989 | 14 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 521 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 840 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2005 | 91 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2004 | 28 | 0.020 |
Why?
|
| Urban Population | 1 | 2004 | 143 | 0.010 |
Why?
|
| Electronics | 2 | 1995 | 9 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2000 | 31 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2000 | 503 | 0.010 |
Why?
|
| Critical Illness | 1 | 1995 | 123 | 0.010 |
Why?
|
| Transducers, Pressure | 1 | 1992 | 4 | 0.010 |
Why?
|